Regen Biopharma, Inc.

$rgbp Chart Analysis

147
upon review bullish divergence can be seen when combining rsi with price action
mac d is coming to retest

candles give off sign we''ve hit the bottom

huge buy of 30k today

descending triangle spotted that may break up or down

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

be careful trading against trends

免责声明

这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。